Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Tezacaftor in Combination With Ivacaftor in Subjects With Cystic Fibrosis Aged 6 Years and Older, Homozygous or Heterozygous for the F508del-CFTR Mutation
Principal Investigator (?)
Study Number
F18046
Summary
This study will evaluate the long-term safety and tolerability of tezacaftor in combination with ivacaftor (TEZ/IVA) in subjects with cystic fibrosis (CF) aged 6 years and older, homozygous or heterozygous for the F508del mutation. 
Phase (?)
Phase III
Sponsor (?)
Contact

Dana Dorman

Available at the following location(s)

Lebanon,Manchester

View more details from ClinicalTrials.gov.

0